FDA Adverse Event Injury Summary report: N

SENZA

MDR report key: 7217598 · Received January 24, 2018

Report

Report Number
3008514029-2018-00097
Event Type
Injury
Date Received
January 24, 2018
Date of Event
February 23, 2017
Report Date
January 24, 2018
Manufacturer
NEVRO CORPORATION
Product Code
LGW
UDI-DI
00813426020015
PMA / PMN Number
P130022
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WAS RETURNED TO NEVRO AND EXAMINED. THE INVESTIGATION CONCLUDED THE NEVRO SYSTEM HAD EXHIBITED NORMAL FUNCTIONALITY. THE MANUFACTURING AND STERILIZATION RECORDS WERE REVIEWED AND NO NON-CONFORMITIES WERE FOUND. BASED ON THE FUNCTIONAL TESTING AND RECORDS REVIEW RESULTS, THE PATIENT'S INFECTION WAS LIKELY DUE TO A PROCEDURAL ISSUE RATHER THAN DEVICE-RELATED.

Description of Event or Problem · 1

IT WAS REPORTED TO NEVRO THAT A PATIENT HAD ACQUIRED AN INFECTION FOLLOWING AN IMPLANT PROCEDURE. THE PATIENT WAS TREATED WITH ORAL ANTIBIOTICS. THERE HAVE BEEN NO FURTHER REPORTS OF COMPLICATIONS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
59808 SENZA NEVRO SENZA LGW NEVRO CORPORATION NIPG1500 9438017 00813426020015

Patients

Seq Age Sex Outcome Treatment
1 68 YR Other